JOURNAL OF BIOLOGICAL CHEMISTRY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2228470, encodeId=f53f22284e025, content=请问需要这个杂志需要整膜WB、三次重复WB或者有marker的WB吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2126388022, createdName=ms9000002133541029, createdTime=Sun Sep 29 22:46:04 CST 2024, time=2024-09-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2279640, encodeId=d7d822e964012, content=确实有一定投稿难度，周刊发行。 收录范围广泛，涵盖生物化学、分子生物学、细胞生物学、生物物理学等领域，像蛋白质结构功能、基因表达调控、信号转导、代谢调控、分子医学等研究都在列。 期刊通常邀请 3 - 4 位审稿人，整体审稿周期差不多14 周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:56:07 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278706, encodeId=f50622e87064c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29b89482515, createdName=ms3000001708217317, createdTime=Mon Aug 25 22:46:42 CST 2025, time=2025-08-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1241694, encodeId=20141241694f2, content=投稿第二天就是“under review”状态，已经18天没变过了，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/a951f2f78b3b45b2bce0604437b55c4b/615b7a88356647b4b643fb43c206bb24.jpg, createdBy=7c902506481, createdName=开车不穿鞋的老司机, createdTime=Sun Aug 28 21:43:55 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275333, encodeId=32b722e533315, content=Under Editorial Consideration 啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20932365973, createdName=122e1c6cm31暂无昵称, createdTime=Tue Jul 29 20:33:38 CST 2025, time=2025-07-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2256705, encodeId=df5e2256e0572, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：24年8月份投的，10月份拿到了审稿意见，12月份返修回去，1月被接收，返修时提供了wb全膜图片，很专业的杂志，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91c5460099, createdName=689993uhnj, createdTime=Wed Mar 19 09:14:19 CST 2025, time=2025-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123760, encodeId=d4752123e6066, content=请问，JBC编辑给了拒稿，但是说可以重投，会送到之前的审稿人手中吗？接受率高不高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Apr 04 22:06:43 CST 2023, time=2023-04-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=843778, encodeId=ddd8843e7857, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是我硕士第二篇文章，过程还算顺利。2月份投稿，20天内收到编辑的邮件，两个reviewers的意见都还不错，但需要补挺多实验进行完善。补来补去弄到了5月底才进行第二次提交，今天收到编辑邮件，说接收啦！不得不说jbc工作效率简直神速！当天就in press了。虽说这几年jbc的if一直在降，但它确实是我们心中的经典杂志，很被业内认可的！能投它我也不会投其他5,6分的杂志的。希望以后继续努力！多发大文章~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Wed Jun 06 15:48:33 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213307, encodeId=a21a221330e13, content=请问这个杂志接收后，原始的WB图需要提供1次，还是3次呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8bc2121464, createdName=1361fac563m, createdTime=Thu Jul 04 22:36:22 CST 2024, time=2024-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144671, encodeId=722121446e142, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：82本自然指数期刊之一，学术性强。一审1个半月，遗憾的是没有给修稿的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Sun Jun 25 17:50:44 CST 2023, time=2023-06-25, status=1, ipAttribution=湖北省)]

2024-09-29 ms9000002133541029 来自云南省

请问需要这个杂志需要整膜WB、三次重复WB或者有marker的WB吗

90 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228470, encodeId=f53f22284e025, content=请问需要这个杂志需要整膜WB、三次重复WB或者有marker的WB吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2126388022, createdName=ms9000002133541029, createdTime=Sun Sep 29 22:46:04 CST 2024, time=2024-09-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2279640, encodeId=d7d822e964012, content=确实有一定投稿难度，周刊发行。 收录范围广泛，涵盖生物化学、分子生物学、细胞生物学、生物物理学等领域，像蛋白质结构功能、基因表达调控、信号转导、代谢调控、分子医学等研究都在列。 期刊通常邀请 3 - 4 位审稿人，整体审稿周期差不多14 周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:56:07 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278706, encodeId=f50622e87064c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29b89482515, createdName=ms3000001708217317, createdTime=Mon Aug 25 22:46:42 CST 2025, time=2025-08-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1241694, encodeId=20141241694f2, content=投稿第二天就是“under review”状态，已经18天没变过了，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/a951f2f78b3b45b2bce0604437b55c4b/615b7a88356647b4b643fb43c206bb24.jpg, createdBy=7c902506481, createdName=开车不穿鞋的老司机, createdTime=Sun Aug 28 21:43:55 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275333, encodeId=32b722e533315, content=Under Editorial Consideration 啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20932365973, createdName=122e1c6cm31暂无昵称, createdTime=Tue Jul 29 20:33:38 CST 2025, time=2025-07-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2256705, encodeId=df5e2256e0572, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：24年8月份投的，10月份拿到了审稿意见，12月份返修回去，1月被接收，返修时提供了wb全膜图片，很专业的杂志，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91c5460099, createdName=689993uhnj, createdTime=Wed Mar 19 09:14:19 CST 2025, time=2025-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123760, encodeId=d4752123e6066, content=请问，JBC编辑给了拒稿，但是说可以重投，会送到之前的审稿人手中吗？接受率高不高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Apr 04 22:06:43 CST 2023, time=2023-04-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=843778, encodeId=ddd8843e7857, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是我硕士第二篇文章，过程还算顺利。2月份投稿，20天内收到编辑的邮件，两个reviewers的意见都还不错，但需要补挺多实验进行完善。补来补去弄到了5月底才进行第二次提交，今天收到编辑邮件，说接收啦！不得不说jbc工作效率简直神速！当天就in press了。虽说这几年jbc的if一直在降，但它确实是我们心中的经典杂志，很被业内认可的！能投它我也不会投其他5,6分的杂志的。希望以后继续努力！多发大文章~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Wed Jun 06 15:48:33 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213307, encodeId=a21a221330e13, content=请问这个杂志接收后，原始的WB图需要提供1次，还是3次呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8bc2121464, createdName=1361fac563m, createdTime=Thu Jul 04 22:36:22 CST 2024, time=2024-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144671, encodeId=722121446e142, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：82本自然指数期刊之一，学术性强。一审1个半月，遗憾的是没有给修稿的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Sun Jun 25 17:50:44 CST 2023, time=2023-06-25, status=1, ipAttribution=湖北省)]

2025-09-01 ms7000002977722172 来自上海

确实有一定投稿难度，周刊发行。
收录范围广泛，涵盖生物化学、分子生物学、细胞生物学、生物物理学等领域，像蛋白质结构功能、基因表达调控、信号转导、代谢调控、分子医学等研究都在列。
期刊通常邀请 3 - 4 位审稿人，整体审稿周期差不多14 周。

23 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2228470, encodeId=f53f22284e025, content=请问需要这个杂志需要整膜WB、三次重复WB或者有marker的WB吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2126388022, createdName=ms9000002133541029, createdTime=Sun Sep 29 22:46:04 CST 2024, time=2024-09-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2279640, encodeId=d7d822e964012, content=确实有一定投稿难度，周刊发行。 收录范围广泛，涵盖生物化学、分子生物学、细胞生物学、生物物理学等领域，像蛋白质结构功能、基因表达调控、信号转导、代谢调控、分子医学等研究都在列。 期刊通常邀请 3 - 4 位审稿人，整体审稿周期差不多14 周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:56:07 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278706, encodeId=f50622e87064c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29b89482515, createdName=ms3000001708217317, createdTime=Mon Aug 25 22:46:42 CST 2025, time=2025-08-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1241694, encodeId=20141241694f2, content=投稿第二天就是“under review”状态，已经18天没变过了，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/a951f2f78b3b45b2bce0604437b55c4b/615b7a88356647b4b643fb43c206bb24.jpg, createdBy=7c902506481, createdName=开车不穿鞋的老司机, createdTime=Sun Aug 28 21:43:55 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275333, encodeId=32b722e533315, content=Under Editorial Consideration 啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20932365973, createdName=122e1c6cm31暂无昵称, createdTime=Tue Jul 29 20:33:38 CST 2025, time=2025-07-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2256705, encodeId=df5e2256e0572, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：24年8月份投的，10月份拿到了审稿意见，12月份返修回去，1月被接收，返修时提供了wb全膜图片，很专业的杂志，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91c5460099, createdName=689993uhnj, createdTime=Wed Mar 19 09:14:19 CST 2025, time=2025-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123760, encodeId=d4752123e6066, content=请问，JBC编辑给了拒稿，但是说可以重投，会送到之前的审稿人手中吗？接受率高不高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Apr 04 22:06:43 CST 2023, time=2023-04-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=843778, encodeId=ddd8843e7857, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是我硕士第二篇文章，过程还算顺利。2月份投稿，20天内收到编辑的邮件，两个reviewers的意见都还不错，但需要补挺多实验进行完善。补来补去弄到了5月底才进行第二次提交，今天收到编辑邮件，说接收啦！不得不说jbc工作效率简直神速！当天就in press了。虽说这几年jbc的if一直在降，但它确实是我们心中的经典杂志，很被业内认可的！能投它我也不会投其他5,6分的杂志的。希望以后继续努力！多发大文章~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Wed Jun 06 15:48:33 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213307, encodeId=a21a221330e13, content=请问这个杂志接收后，原始的WB图需要提供1次，还是3次呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8bc2121464, createdName=1361fac563m, createdTime=Thu Jul 04 22:36:22 CST 2024, time=2024-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144671, encodeId=722121446e142, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：82本自然指数期刊之一，学术性强。一审1个半月，遗憾的是没有给修稿的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Sun Jun 25 17:50:44 CST 2023, time=2023-06-25, status=1, ipAttribution=湖北省)]

2025-08-25 ms3000001708217317 来自陕西省

审稿速度:2.0 | 投稿命中率:25.0
经验分享：难投

15 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228470, encodeId=f53f22284e025, content=请问需要这个杂志需要整膜WB、三次重复WB或者有marker的WB吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2126388022, createdName=ms9000002133541029, createdTime=Sun Sep 29 22:46:04 CST 2024, time=2024-09-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2279640, encodeId=d7d822e964012, content=确实有一定投稿难度，周刊发行。 收录范围广泛，涵盖生物化学、分子生物学、细胞生物学、生物物理学等领域，像蛋白质结构功能、基因表达调控、信号转导、代谢调控、分子医学等研究都在列。 期刊通常邀请 3 - 4 位审稿人，整体审稿周期差不多14 周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:56:07 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278706, encodeId=f50622e87064c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29b89482515, createdName=ms3000001708217317, createdTime=Mon Aug 25 22:46:42 CST 2025, time=2025-08-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1241694, encodeId=20141241694f2, content=投稿第二天就是“under review”状态，已经18天没变过了，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/a951f2f78b3b45b2bce0604437b55c4b/615b7a88356647b4b643fb43c206bb24.jpg, createdBy=7c902506481, createdName=开车不穿鞋的老司机, createdTime=Sun Aug 28 21:43:55 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275333, encodeId=32b722e533315, content=Under Editorial Consideration 啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20932365973, createdName=122e1c6cm31暂无昵称, createdTime=Tue Jul 29 20:33:38 CST 2025, time=2025-07-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2256705, encodeId=df5e2256e0572, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：24年8月份投的，10月份拿到了审稿意见，12月份返修回去，1月被接收，返修时提供了wb全膜图片，很专业的杂志，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91c5460099, createdName=689993uhnj, createdTime=Wed Mar 19 09:14:19 CST 2025, time=2025-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123760, encodeId=d4752123e6066, content=请问，JBC编辑给了拒稿，但是说可以重投，会送到之前的审稿人手中吗？接受率高不高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Apr 04 22:06:43 CST 2023, time=2023-04-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=843778, encodeId=ddd8843e7857, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是我硕士第二篇文章，过程还算顺利。2月份投稿，20天内收到编辑的邮件，两个reviewers的意见都还不错，但需要补挺多实验进行完善。补来补去弄到了5月底才进行第二次提交，今天收到编辑邮件，说接收啦！不得不说jbc工作效率简直神速！当天就in press了。虽说这几年jbc的if一直在降，但它确实是我们心中的经典杂志，很被业内认可的！能投它我也不会投其他5,6分的杂志的。希望以后继续努力！多发大文章~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Wed Jun 06 15:48:33 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213307, encodeId=a21a221330e13, content=请问这个杂志接收后，原始的WB图需要提供1次，还是3次呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8bc2121464, createdName=1361fac563m, createdTime=Thu Jul 04 22:36:22 CST 2024, time=2024-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144671, encodeId=722121446e142, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：82本自然指数期刊之一，学术性强。一审1个半月，遗憾的是没有给修稿的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Sun Jun 25 17:50:44 CST 2023, time=2023-06-25, status=1, ipAttribution=湖北省)]

2022-08-28 开车不穿鞋的老司机

投稿第二天就是“under review”状态，已经18天没变过了，需要催一下编辑吗？

201 8 举报

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228470, encodeId=f53f22284e025, content=请问需要这个杂志需要整膜WB、三次重复WB或者有marker的WB吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2126388022, createdName=ms9000002133541029, createdTime=Sun Sep 29 22:46:04 CST 2024, time=2024-09-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2279640, encodeId=d7d822e964012, content=确实有一定投稿难度，周刊发行。 收录范围广泛，涵盖生物化学、分子生物学、细胞生物学、生物物理学等领域，像蛋白质结构功能、基因表达调控、信号转导、代谢调控、分子医学等研究都在列。 期刊通常邀请 3 - 4 位审稿人，整体审稿周期差不多14 周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:56:07 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278706, encodeId=f50622e87064c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29b89482515, createdName=ms3000001708217317, createdTime=Mon Aug 25 22:46:42 CST 2025, time=2025-08-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1241694, encodeId=20141241694f2, content=投稿第二天就是“under review”状态，已经18天没变过了，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/a951f2f78b3b45b2bce0604437b55c4b/615b7a88356647b4b643fb43c206bb24.jpg, createdBy=7c902506481, createdName=开车不穿鞋的老司机, createdTime=Sun Aug 28 21:43:55 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275333, encodeId=32b722e533315, content=Under Editorial Consideration 啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20932365973, createdName=122e1c6cm31暂无昵称, createdTime=Tue Jul 29 20:33:38 CST 2025, time=2025-07-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2256705, encodeId=df5e2256e0572, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：24年8月份投的，10月份拿到了审稿意见，12月份返修回去，1月被接收，返修时提供了wb全膜图片，很专业的杂志，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91c5460099, createdName=689993uhnj, createdTime=Wed Mar 19 09:14:19 CST 2025, time=2025-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123760, encodeId=d4752123e6066, content=请问，JBC编辑给了拒稿，但是说可以重投，会送到之前的审稿人手中吗？接受率高不高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Apr 04 22:06:43 CST 2023, time=2023-04-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=843778, encodeId=ddd8843e7857, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是我硕士第二篇文章，过程还算顺利。2月份投稿，20天内收到编辑的邮件，两个reviewers的意见都还不错，但需要补挺多实验进行完善。补来补去弄到了5月底才进行第二次提交，今天收到编辑邮件，说接收啦！不得不说jbc工作效率简直神速！当天就in press了。虽说这几年jbc的if一直在降，但它确实是我们心中的经典杂志，很被业内认可的！能投它我也不会投其他5,6分的杂志的。希望以后继续努力！多发大文章~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Wed Jun 06 15:48:33 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213307, encodeId=a21a221330e13, content=请问这个杂志接收后，原始的WB图需要提供1次，还是3次呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8bc2121464, createdName=1361fac563m, createdTime=Thu Jul 04 22:36:22 CST 2024, time=2024-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144671, encodeId=722121446e142, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：82本自然指数期刊之一，学术性强。一审1个半月，遗憾的是没有给修稿的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Sun Jun 25 17:50:44 CST 2023, time=2023-06-25, status=1, ipAttribution=湖北省)]

2025-07-29 122e1c6cm31暂无昵称来自山东省

Under Editorial Consideration 啥意思

29 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228470, encodeId=f53f22284e025, content=请问需要这个杂志需要整膜WB、三次重复WB或者有marker的WB吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2126388022, createdName=ms9000002133541029, createdTime=Sun Sep 29 22:46:04 CST 2024, time=2024-09-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2279640, encodeId=d7d822e964012, content=确实有一定投稿难度，周刊发行。 收录范围广泛，涵盖生物化学、分子生物学、细胞生物学、生物物理学等领域，像蛋白质结构功能、基因表达调控、信号转导、代谢调控、分子医学等研究都在列。 期刊通常邀请 3 - 4 位审稿人，整体审稿周期差不多14 周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:56:07 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278706, encodeId=f50622e87064c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29b89482515, createdName=ms3000001708217317, createdTime=Mon Aug 25 22:46:42 CST 2025, time=2025-08-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1241694, encodeId=20141241694f2, content=投稿第二天就是“under review”状态，已经18天没变过了，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/a951f2f78b3b45b2bce0604437b55c4b/615b7a88356647b4b643fb43c206bb24.jpg, createdBy=7c902506481, createdName=开车不穿鞋的老司机, createdTime=Sun Aug 28 21:43:55 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275333, encodeId=32b722e533315, content=Under Editorial Consideration 啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20932365973, createdName=122e1c6cm31暂无昵称, createdTime=Tue Jul 29 20:33:38 CST 2025, time=2025-07-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2256705, encodeId=df5e2256e0572, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：24年8月份投的，10月份拿到了审稿意见，12月份返修回去，1月被接收，返修时提供了wb全膜图片，很专业的杂志，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91c5460099, createdName=689993uhnj, createdTime=Wed Mar 19 09:14:19 CST 2025, time=2025-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123760, encodeId=d4752123e6066, content=请问，JBC编辑给了拒稿，但是说可以重投，会送到之前的审稿人手中吗？接受率高不高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Apr 04 22:06:43 CST 2023, time=2023-04-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=843778, encodeId=ddd8843e7857, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是我硕士第二篇文章，过程还算顺利。2月份投稿，20天内收到编辑的邮件，两个reviewers的意见都还不错，但需要补挺多实验进行完善。补来补去弄到了5月底才进行第二次提交，今天收到编辑邮件，说接收啦！不得不说jbc工作效率简直神速！当天就in press了。虽说这几年jbc的if一直在降，但它确实是我们心中的经典杂志，很被业内认可的！能投它我也不会投其他5,6分的杂志的。希望以后继续努力！多发大文章~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Wed Jun 06 15:48:33 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213307, encodeId=a21a221330e13, content=请问这个杂志接收后，原始的WB图需要提供1次，还是3次呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8bc2121464, createdName=1361fac563m, createdTime=Thu Jul 04 22:36:22 CST 2024, time=2024-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144671, encodeId=722121446e142, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：82本自然指数期刊之一，学术性强。一审1个半月，遗憾的是没有给修稿的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Sun Jun 25 17:50:44 CST 2023, time=2023-06-25, status=1, ipAttribution=湖北省)]

2025-03-19 689993uhnj 来自陕西省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：24年8月份投的，10月份拿到了审稿意见，12月份返修回去，1月被接收，返修时提供了wb全膜图片，很专业的杂志，

49 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2228470, encodeId=f53f22284e025, content=请问需要这个杂志需要整膜WB、三次重复WB或者有marker的WB吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2126388022, createdName=ms9000002133541029, createdTime=Sun Sep 29 22:46:04 CST 2024, time=2024-09-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2279640, encodeId=d7d822e964012, content=确实有一定投稿难度，周刊发行。 收录范围广泛，涵盖生物化学、分子生物学、细胞生物学、生物物理学等领域，像蛋白质结构功能、基因表达调控、信号转导、代谢调控、分子医学等研究都在列。 期刊通常邀请 3 - 4 位审稿人，整体审稿周期差不多14 周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:56:07 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278706, encodeId=f50622e87064c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29b89482515, createdName=ms3000001708217317, createdTime=Mon Aug 25 22:46:42 CST 2025, time=2025-08-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1241694, encodeId=20141241694f2, content=投稿第二天就是“under review”状态，已经18天没变过了，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/a951f2f78b3b45b2bce0604437b55c4b/615b7a88356647b4b643fb43c206bb24.jpg, createdBy=7c902506481, createdName=开车不穿鞋的老司机, createdTime=Sun Aug 28 21:43:55 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275333, encodeId=32b722e533315, content=Under Editorial Consideration 啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20932365973, createdName=122e1c6cm31暂无昵称, createdTime=Tue Jul 29 20:33:38 CST 2025, time=2025-07-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2256705, encodeId=df5e2256e0572, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：24年8月份投的，10月份拿到了审稿意见，12月份返修回去，1月被接收，返修时提供了wb全膜图片，很专业的杂志，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91c5460099, createdName=689993uhnj, createdTime=Wed Mar 19 09:14:19 CST 2025, time=2025-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123760, encodeId=d4752123e6066, content=请问，JBC编辑给了拒稿，但是说可以重投，会送到之前的审稿人手中吗？接受率高不高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Apr 04 22:06:43 CST 2023, time=2023-04-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=843778, encodeId=ddd8843e7857, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是我硕士第二篇文章，过程还算顺利。2月份投稿，20天内收到编辑的邮件，两个reviewers的意见都还不错，但需要补挺多实验进行完善。补来补去弄到了5月底才进行第二次提交，今天收到编辑邮件，说接收啦！不得不说jbc工作效率简直神速！当天就in press了。虽说这几年jbc的if一直在降，但它确实是我们心中的经典杂志，很被业内认可的！能投它我也不会投其他5,6分的杂志的。希望以后继续努力！多发大文章~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Wed Jun 06 15:48:33 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213307, encodeId=a21a221330e13, content=请问这个杂志接收后，原始的WB图需要提供1次，还是3次呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8bc2121464, createdName=1361fac563m, createdTime=Thu Jul 04 22:36:22 CST 2024, time=2024-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144671, encodeId=722121446e142, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：82本自然指数期刊之一，学术性强。一审1个半月，遗憾的是没有给修稿的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Sun Jun 25 17:50:44 CST 2023, time=2023-06-25, status=1, ipAttribution=湖北省)]

2023-04-04 ms9000001460504456 来自广东省

请问，JBC编辑给了拒稿，但是说可以重投，会送到之前的审稿人手中吗？接受率高不高？

171 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228470, encodeId=f53f22284e025, content=请问需要这个杂志需要整膜WB、三次重复WB或者有marker的WB吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2126388022, createdName=ms9000002133541029, createdTime=Sun Sep 29 22:46:04 CST 2024, time=2024-09-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2279640, encodeId=d7d822e964012, content=确实有一定投稿难度，周刊发行。 收录范围广泛，涵盖生物化学、分子生物学、细胞生物学、生物物理学等领域，像蛋白质结构功能、基因表达调控、信号转导、代谢调控、分子医学等研究都在列。 期刊通常邀请 3 - 4 位审稿人，整体审稿周期差不多14 周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:56:07 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278706, encodeId=f50622e87064c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29b89482515, createdName=ms3000001708217317, createdTime=Mon Aug 25 22:46:42 CST 2025, time=2025-08-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1241694, encodeId=20141241694f2, content=投稿第二天就是“under review”状态，已经18天没变过了，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/a951f2f78b3b45b2bce0604437b55c4b/615b7a88356647b4b643fb43c206bb24.jpg, createdBy=7c902506481, createdName=开车不穿鞋的老司机, createdTime=Sun Aug 28 21:43:55 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275333, encodeId=32b722e533315, content=Under Editorial Consideration 啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20932365973, createdName=122e1c6cm31暂无昵称, createdTime=Tue Jul 29 20:33:38 CST 2025, time=2025-07-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2256705, encodeId=df5e2256e0572, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：24年8月份投的，10月份拿到了审稿意见，12月份返修回去，1月被接收，返修时提供了wb全膜图片，很专业的杂志，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91c5460099, createdName=689993uhnj, createdTime=Wed Mar 19 09:14:19 CST 2025, time=2025-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123760, encodeId=d4752123e6066, content=请问，JBC编辑给了拒稿，但是说可以重投，会送到之前的审稿人手中吗？接受率高不高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Apr 04 22:06:43 CST 2023, time=2023-04-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=843778, encodeId=ddd8843e7857, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是我硕士第二篇文章，过程还算顺利。2月份投稿，20天内收到编辑的邮件，两个reviewers的意见都还不错，但需要补挺多实验进行完善。补来补去弄到了5月底才进行第二次提交，今天收到编辑邮件，说接收啦！不得不说jbc工作效率简直神速！当天就in press了。虽说这几年jbc的if一直在降，但它确实是我们心中的经典杂志，很被业内认可的！能投它我也不会投其他5,6分的杂志的。希望以后继续努力！多发大文章~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Wed Jun 06 15:48:33 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213307, encodeId=a21a221330e13, content=请问这个杂志接收后，原始的WB图需要提供1次，还是3次呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8bc2121464, createdName=1361fac563m, createdTime=Thu Jul 04 22:36:22 CST 2024, time=2024-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144671, encodeId=722121446e142, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：82本自然指数期刊之一，学术性强。一审1个半月，遗憾的是没有给修稿的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Sun Jun 25 17:50:44 CST 2023, time=2023-06-25, status=1, ipAttribution=湖北省)]

2018-06-06 ms8341280369405896

审稿速度:3.0 | 投稿命中率:75.0
经验分享：这是我硕士第二篇文章，过程还算顺利。2月份投稿，20天内收到编辑的邮件，两个reviewers的意见都还不错，但需要补挺多实验进行完善。补来补去弄到了5月底才进行第二次提交，今天收到编辑邮件，说接收啦！不得不说jbc工作效率简直神速！当天就in press了。虽说这几年jbc的if一直在降，但它确实是我们心中的经典杂志，很被业内认可的！能投它我也不会投其他5,6分的杂志的。希望以后继续努力！多发大文章~

272 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228470, encodeId=f53f22284e025, content=请问需要这个杂志需要整膜WB、三次重复WB或者有marker的WB吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2126388022, createdName=ms9000002133541029, createdTime=Sun Sep 29 22:46:04 CST 2024, time=2024-09-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2279640, encodeId=d7d822e964012, content=确实有一定投稿难度，周刊发行。 收录范围广泛，涵盖生物化学、分子生物学、细胞生物学、生物物理学等领域，像蛋白质结构功能、基因表达调控、信号转导、代谢调控、分子医学等研究都在列。 期刊通常邀请 3 - 4 位审稿人，整体审稿周期差不多14 周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:56:07 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278706, encodeId=f50622e87064c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29b89482515, createdName=ms3000001708217317, createdTime=Mon Aug 25 22:46:42 CST 2025, time=2025-08-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1241694, encodeId=20141241694f2, content=投稿第二天就是“under review”状态，已经18天没变过了，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/a951f2f78b3b45b2bce0604437b55c4b/615b7a88356647b4b643fb43c206bb24.jpg, createdBy=7c902506481, createdName=开车不穿鞋的老司机, createdTime=Sun Aug 28 21:43:55 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275333, encodeId=32b722e533315, content=Under Editorial Consideration 啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20932365973, createdName=122e1c6cm31暂无昵称, createdTime=Tue Jul 29 20:33:38 CST 2025, time=2025-07-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2256705, encodeId=df5e2256e0572, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：24年8月份投的，10月份拿到了审稿意见，12月份返修回去，1月被接收，返修时提供了wb全膜图片，很专业的杂志，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91c5460099, createdName=689993uhnj, createdTime=Wed Mar 19 09:14:19 CST 2025, time=2025-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123760, encodeId=d4752123e6066, content=请问，JBC编辑给了拒稿，但是说可以重投，会送到之前的审稿人手中吗？接受率高不高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Apr 04 22:06:43 CST 2023, time=2023-04-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=843778, encodeId=ddd8843e7857, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是我硕士第二篇文章，过程还算顺利。2月份投稿，20天内收到编辑的邮件，两个reviewers的意见都还不错，但需要补挺多实验进行完善。补来补去弄到了5月底才进行第二次提交，今天收到编辑邮件，说接收啦！不得不说jbc工作效率简直神速！当天就in press了。虽说这几年jbc的if一直在降，但它确实是我们心中的经典杂志，很被业内认可的！能投它我也不会投其他5,6分的杂志的。希望以后继续努力！多发大文章~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Wed Jun 06 15:48:33 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213307, encodeId=a21a221330e13, content=请问这个杂志接收后，原始的WB图需要提供1次，还是3次呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8bc2121464, createdName=1361fac563m, createdTime=Thu Jul 04 22:36:22 CST 2024, time=2024-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144671, encodeId=722121446e142, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：82本自然指数期刊之一，学术性强。一审1个半月，遗憾的是没有给修稿的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Sun Jun 25 17:50:44 CST 2023, time=2023-06-25, status=1, ipAttribution=湖北省)]

2024-07-04 1361fac563m 来自四川省

请问这个杂志接收后，原始的WB图需要提供1次，还是3次呢？

162 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228470, encodeId=f53f22284e025, content=请问需要这个杂志需要整膜WB、三次重复WB或者有marker的WB吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2126388022, createdName=ms9000002133541029, createdTime=Sun Sep 29 22:46:04 CST 2024, time=2024-09-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2279640, encodeId=d7d822e964012, content=确实有一定投稿难度，周刊发行。 收录范围广泛，涵盖生物化学、分子生物学、细胞生物学、生物物理学等领域，像蛋白质结构功能、基因表达调控、信号转导、代谢调控、分子医学等研究都在列。 期刊通常邀请 3 - 4 位审稿人，整体审稿周期差不多14 周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:56:07 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2278706, encodeId=f50622e87064c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29b89482515, createdName=ms3000001708217317, createdTime=Mon Aug 25 22:46:42 CST 2025, time=2025-08-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1241694, encodeId=20141241694f2, content=投稿第二天就是“under review”状态，已经18天没变过了，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/a951f2f78b3b45b2bce0604437b55c4b/615b7a88356647b4b643fb43c206bb24.jpg, createdBy=7c902506481, createdName=开车不穿鞋的老司机, createdTime=Sun Aug 28 21:43:55 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275333, encodeId=32b722e533315, content=Under Editorial Consideration 啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20932365973, createdName=122e1c6cm31暂无昵称, createdTime=Tue Jul 29 20:33:38 CST 2025, time=2025-07-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2256705, encodeId=df5e2256e0572, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：24年8月份投的，10月份拿到了审稿意见，12月份返修回去，1月被接收，返修时提供了wb全膜图片，很专业的杂志，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91c5460099, createdName=689993uhnj, createdTime=Wed Mar 19 09:14:19 CST 2025, time=2025-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123760, encodeId=d4752123e6066, content=请问，JBC编辑给了拒稿，但是说可以重投，会送到之前的审稿人手中吗？接受率高不高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Tue Apr 04 22:06:43 CST 2023, time=2023-04-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=843778, encodeId=ddd8843e7857, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：这是我硕士第二篇文章，过程还算顺利。2月份投稿，20天内收到编辑的邮件，两个reviewers的意见都还不错，但需要补挺多实验进行完善。补来补去弄到了5月底才进行第二次提交，今天收到编辑邮件，说接收啦！不得不说jbc工作效率简直神速！当天就in press了。虽说这几年jbc的if一直在降，但它确实是我们心中的经典杂志，很被业内认可的！能投它我也不会投其他5,6分的杂志的。希望以后继续努力！多发大文章~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Wed Jun 06 15:48:33 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213307, encodeId=a21a221330e13, content=请问这个杂志接收后，原始的WB图需要提供1次，还是3次呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8bc2121464, createdName=1361fac563m, createdTime=Thu Jul 04 22:36:22 CST 2024, time=2024-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144671, encodeId=722121446e142, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：82本自然指数期刊之一，学术性强。一审1个半月，遗憾的是没有给修稿的机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Sun Jun 25 17:50:44 CST 2023, time=2023-06-25, status=1, ipAttribution=湖北省)]

2023-06-25 山蛙来自湖北省

审稿速度:2.0 | 投稿命中率:25.0
经验分享：82本自然指数期刊之一，学术性强。一审1个半月，遗憾的是没有给修稿的机会。

213 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务